| P50 | author | Akira Shimada | Q57578382 |
| P2093 | author name string | Keizo Horibe | |
| | Shotaro Iwamoto | |
| | Hiroyuki Takahashi | |
| | Takashi Taga | |
| | Yasuhide Hayashi | |
| | Katsuyoshi Koh | |
| | Hiroshi Moritake | |
| | Nobutaka Kiyokawa | |
| | Hideki Nakayama | |
| | Souichi Adachi | |
| | Kiminori Terui | |
| | Tomoyuki Watanabe | |
| | Daisuke Tomizawa | |
| | Shiro Tanaka | |
| | Yusuke Hara | |
| | Akitoshi Kinoshita | |
| | Akiko Moriya Saito | |
| | Hiroaki Goto | |
| | Yoshiyuki Kosaka | |
| | Akio Tawa | |
| | Kentaro Oki | |
| | Miho Yamada | |
| | Yuka Iijima-Yamashita | |
| | Shiba Norio | |
| P2860 | cites work | The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia | Q27851416 |
| | Impact of FLT3(ITD) mutant allele level on relapse risk in intermediate-risk acute myeloid leukemia. | Q27853008 |
| | TET2 gene mutation is unfavorable prognostic factor in cytogenetically normal acute myeloid leukemia patients with NPM1+ and FLT3-ITD - mutations | Q27853009 |
| | Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia | Q31774863 |
| | NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report | Q34318490 |
| | Clinical implications of FLT3 mutations in pediatric AML. | Q35848876 |
| | FLT3 inhibitors for acute myeloid leukemia: a review of their efficacy and mechanisms of resistance | Q38101284 |
| | Differential impact of allelic ratio and insertion site in FLT3-ITD-positive AML with respect to allogeneic transplantation | Q38422959 |
| | FLT3 Inhibitors in Acute Myeloid Leukemia: Current Status and Future Directions | Q38675400 |
| | Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation | Q38712298 |
| | Internal tandem duplication of FLT3 deregulates proliferation and differentiation and confers resistance to the FLT3 inhibitor AC220 by Up-regulating RUNX1 expression in hematopoietic cells | Q40293334 |
| | Sorafenib and azacitidine as salvage therapy for relapse of FLT3-ITD mutated AML after allo-SCT. | Q40454294 |
| | Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3-ITD acute myeloid leukaemia in first complete remission | Q40513646 |
| | WT1 mutation in pediatric patients with acute myeloid leukemia: a report from the Japanese Childhood AML Cooperative Study Group | Q44097808 |
| | NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia | Q44123939 |
| | FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance | Q44484460 |
| | Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome. | Q45929224 |
| | Medium-sized FLT3 internal tandem duplications confer worse prognosis than short and long duplications in a non-elderly acute myeloid leukemia cohort. | Q46576832 |
| | Positive Minimal Residual Disease of FLT3-ITD before Hematopoietic Stem Cell Transplantation Resulted in a Poor Prognosis of an Acute Myeloid Leukemia. | Q51122226 |
| | RAS mutations are frequent in FAB type M4 and M5 of acute myeloid leukemia, and related to late relapse: a study of the Japanese Childhood AML Cooperative Study Group. | Q53384430 |
| | High WT1 mRNA expression after induction chemotherapy and FLT3-ITD have prognostic impact in pediatric acute myeloid leukemia: a study of the Japanese Childhood AML Cooperative Study Group. | Q54488953 |
| | Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia | Q57415017 |
| | Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy | Q62078641 |
| | Tandem duplications of MLL and FLT3 are correlated with poor prognoses in pediatric acute myeloid leukemia: a study of the Japanese childhood AML Cooperative Study Group | Q80974291 |
| | NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern | Q84668776 |
| | Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group | Q86040728 |
| P433 | issue | 5 | |
| P921 | main subject | leukemia | Q29496 |
| | acute myeloid leukemia | Q264118 |
| P304 | page(s) | 586-595 | |
| P577 | publication date | 2018-01-12 | |
| P1433 | published in | International Journal of Hematology | Q6051416 |
| P1476 | title | Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 study | |
| P478 | volume | 107 | |